111, Inc.
YI
NASDAQ·Healthcare·Medical - Distribution·Mkt cap $30.3M
$3.47
▲ +4.05%
P/E
-2.39
Mkt Cap
$30.3M
52-Wk Range
$2.48–$11.17
52-Week Range
$2.48 - $11.17
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 39.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.7).
Growth
Strong growth ahead
Value
Valuation data unavailable
Momentum
Falling
-26.9% over 3m
Quality
Thin
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying YI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 31, 2026
Most recent quarter reported revenue of $349.0M. Reported EPS of -$0.62.
Reported EPS · last 4Q
Q1 26
-$0.62
Q4 25
-$0.27
Q3 25
-$0.22
Q2 25
-$0.33
Revenue trend · last 8Q
—
—
—
—
-6%
-17%
-28%
-34%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$510.2M
$536.5M
$573.3M
$525.8M
$477.6M
$447.1M
$414.4M
$349.0M
Margins · last 8Q
Profit
-1.6%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How YI stacks vs Medical - Distribution
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.